StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed r&d expenses

Research and development expenses are spending on new products and technology.

CervoMed's R&D Expenses for the twelve months ending Jun 30, 2026 was $21.33M, down 3.7% year over year. For fiscal 2025 it was $21.82M, up 16.1% from the year before. Over ten years it grew 18.9% a year on average. The highest annual figure on record is $21.82M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.82M+16.1%
FY2024Dec 31, 2024$18.80M+122.8%
FY2023Dec 31, 2023$8.44M+531.4%
FY2022Dec 31, 2022$1.34M-84.3%
FY2021Dec 31, 2021$8.50M-9.8%
FY2020Dec 31, 2020$9.43M+42.4%
FY2019Dec 31, 2019$6.62M+15.1%
FY2018Dec 31, 2018$5.75M+13.0%
FY2017Dec 31, 2017$5.09M-29.8%
FY2016Dec 31, 2016$7.25M+87.1%
FY2015Dec 31, 2015$3.88M+35.5%
FY2014Dec 31, 2014$2.86M+734.2%
FY2013Dec 31, 2013$342.92K–
FY2011Dec 31, 2011$0–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.32M-15.4%
Q1 FY2026Mar 31, 2026$5.14M+6.2%
Q4 FY2025Dec 31, 2025$5.83M-17.7%
Q3 FY2025Sep 30, 2025$6.04M+17.9%
Q2 FY2025Jun 30, 2025$5.11M+35.4%
Q1 FY2025Mar 31, 2025$4.84M+71.9%
Q4 FY2024Dec 31, 2024$7.09M+148.2%
Q3 FY2024Sep 30, 2024$5.13M+186.1%
Q2 FY2024Jun 30, 2024$3.77M+92.6%
Q1 FY2024Mar 31, 2024$2.81M+53.5%
Q4 FY2023Dec 31, 2023$2.86M+650.1%
Q3 FY2023Sep 30, 2023$1.79M+442.0%
Q2 FY2023Jun 30, 2023$1.96M-7.1%
Q1 FY2023Mar 31, 2023$1.83M-24.4%
Q4 FY2022Dec 31, 2022$380.69K-74.7%
Q3 FY2022Sep 30, 2022$330.54K-84.3%
Q2 FY2022Jun 30, 2022$2.11M+6.9%
Q1 FY2022Mar 31, 2022$2.43M-16.8%
Q4 FY2021Dec 31, 2021$1.50M-41.7%
Q3 FY2021Sep 30, 2021$2.11M-32.9%
Q2 FY2021Jun 30, 2021$1.97M-9.2%
Q1 FY2021Mar 31, 2021$2.92M+90.1%
Q4 FY2020Dec 31, 2020$2.58M+55.8%
Q3 FY2020Sep 30, 2020$3.14M+80.0%
Q2 FY2020Jun 30, 2020$2.17M+43.1%
Q1 FY2020Mar 31, 2020$1.53M-9.7%
Q4 FY2019Dec 31, 2019$1.66M+21.4%
Q3 FY2019Sep 30, 2019$1.74M+49.0%
Q2 FY2019Jun 30, 2019$1.52M+9.1%
Q1 FY2019Mar 31, 2019$1.70M-6.9%
Q4 FY2018Dec 31, 2018$1.37M+19.5%
Q3 FY2018Sep 30, 2018$1.17M-33.5%
Q2 FY2018Jun 30, 2018$1.39M+17.9%
Q1 FY2018Mar 31, 2018$1.83M+81.2%
Q4 FY2017Dec 31, 2017$1.14M-24.5%
Q3 FY2017Sep 30, 2017$1.76M-9.4%
Q2 FY2017Jun 30, 2017$1.18M–
Q1 FY2017Mar 31, 2017$1.01M–
Q4 FY2016Dec 31, 2016$1.51M–
Q3 FY2016Sep 30, 2016$1.94M–

More CervoMed figures

See a number that looks wrong?